Baula has been seclected to become part of the FuTUR Impact program of Ship2B Blog Post

Clean & Health & Eco Baula has been one of the two companies selected to become part of the  FuTUR Impact program, the investment and acceleration platform for high social impact startups in the sector of tourism of the Ship2B Foundation. The company, based at the Barcelona Science Park, has developed an innovative and patented formula worldwide to manufacture and distribute any cleaning product, in the form of individual tablets and easy dissolution, 100% sustainable and responsible to the environment. 

 

Awards of the UB Board of Trustees and the FBG: Ten years fostering knowledge transfer Blog Post

The Awards of the Board of Trustees of the University of Barcelona (UB) and Bosch i Gimpera Foundation (FBG) –based at the Barcelona Science Park (PCB)– celebrate their tenth edition. These prizes are awarded in two categories: the Antoni Caparrós Prize for the best knowledge transfer project, and the Senén Vilaró Prize for the best innovative company which, since its creation in 2008, has recognized eight companies based at PCB: Meteosim, Biocontrol Technologies, Intelligent Pharma, Enantia, Neurotec Pharma, Infinitec Assets, Endor Technologies and Minoryx Therapeutics.

 

BIST awards the first five Ignite multidisciplinary projects Blog Post

In the framework of the BIST Founding Conference –held last Friday at the Center for Contemporary Culture of Barcelona– the Barcelona Institute of Science and Technology (BIST) –located at the Barcelona Science Park– announced the five winning proposals for the 1st BIST Ignite call. The program takes place in two phases: in the first, the selected projects will receive 20,000€ each. By the end of 2017, the two projects with the highest potential will be selected to receive additional funding of 50,000€.

 

Transgenic plants against malaria Blog Post

An international research team led by researchers from the Centre for Research in Agricultural Genomics (CRAG) and the spin-out Sequentia Biotech based at the Barcelona Science Park has been able to obtain, through genetic engineering, Artemisia annua plants that produce twice as much artemisinin molecule, the main component of malaria treatments worldwide. This finding could be a major step towards reducing the production costs of antimalarial drugs.

 

Bionure project of the GAEM’s Accelerator Programme raises more than €1M via equity crowdfunding Blog Post

With more than €1M raised, Bionure’s campaign ‘#estamosaesto‘ (‘we are this close’) is currently overfunding on the Capital Cell crowdfunding platform.These funds will be used by the company to develop BN201, a promising first-in-class drug candidate halt the development of Multiple Sclerosis (MS). Bionure’s MS drug candidate is one of the projects promotes by the Accelerator Programme of GAEM Foundation from its headquarters at the Barcelona Science Park (PCB).

 

The Barcelona Science Park has strong presence at BIO-Europe Spring Blog Post

BIO-Europe Spring (BES) –the spring edition of the most important partnering congress in the biotechnology and pharmaceutical industry in Europe– returns to Barcelona in 20-22 March 2017 at the CCIB Convention Centre. After the success of the 2010 and 2013 editions, more than 100 companies and organizations from the BioRegion will be participating in the fair, twice as many as the previous year. This edition features remarkable presence of the Barcelona Science Park (PCB) and a large number of companies and entities from PCB Community.

 

New research front to tackle Friedreich’s Ataxia Blog Post

The associations of patients and families Babel Family and the Asociación Granadina de la Ataxia de Friedreich (ASOGAF) channel 80,000 euros of their donations (50% from each organisation) into a new 18-month project at the Institute for Research in Biomedicine (IRB Barcelona) located at PCB. The long-term goal of the project is to achieve an injectable frataxin treatment able to reach the brain. Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.

 

The Futbol Club Barcelona Foundation moves its headquarters to Barcelona Science Park Blog Post

The Futbol Club Barcelona Foundation –the entity through which Futbol Club Barcelona conveys its corporate social responsibility– has taken a step forwards its growth and future projection by changing their main headquarters to the Barcelona Science Park building complex.The new premises will imply the entity can enjoy a quite wider space and a major growth.The old premises were previously located at the Social Area building of FC Barcelona.